BC
ACAD icon

Burney Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Burney Company’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$229K Sell
9,049
-50,921
-85% -$1.12M 0.01% 581
2026
Q1 		$1.33M Sell
59,970
-45,441
-43% -$1.09M 0.04% 278
2025
Q4 		$2.82M Sell
105,411
-1,726
-2% -$41.2K 0.09% 198
2025
Q3 		$2.29M Sell
107,137
-6,615
-6% -$156K 0.07% 216
2025
Q2 		$2.45M Sell
113,752
-284,340
-71% -$5.29M 0.08% 202
2025
Q1 		$6.61M Buy
398,092
+19,189
+5% +$349K 0.24% 93
2024
Q4 		$6.95M Buy
+378,903
New +$6.12M 0.25% 89

Other funds holding ACAD

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Burney Company's ACAD Position: Q2 2026 in Review

Burney Company reduced its Acadia Pharmaceuticals (ACAD) stake by 85% in Q2 2026, selling an estimated $1.12M and leaving 9,049 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #581.

Burney Company first reported a position in ACAD in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.95M in Q4 2024. 29 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • Burney Company held 9,049 shares of Acadia Pharmaceuticals worth $229K as of Q2 2026.
  • Burney Company sold 50,921 Acadia Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Acadia Pharmaceuticals made up 0.01% of Burney Company's portfolio in Q2 2026, its #581 holding.
  • Burney Company first reported a position in Acadia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Burney Company's Acadia Pharmaceuticals position peaked at $6.95M in Q4 2024.
  • 29 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.